$50.58
-0.27-0.54%
Last update: Dec 16, 3:23 PM
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
ALPS Medical Breakthroughs ETF (SBIO) Stock Price, Quote, News & History
SBIOARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
120.32M
Fund Score
Key Statistics
Open
$50.93
High
$50.93
52 Wk High
$51.87
AUM
120.32M
Dividend
$0.62
Ex-Div Date
Dec 19, 2024
Volume
52.3K
Market Cap
$2.66B
Mgmt Fee
0.5%
P/E Ratio
10.85
Prev. Close
$50.86
Low
$50.00
52 Wk Low
$22.33
Shares Out
3.20M
Yield
1.21%
Div. Freq
-
Avg. Volume Daily
41.50K
Beta
0.79
Avg. Expense Ratio
0.5%
P/B Ratio
3.15
Recent ALPS Medical Breakthroughs ETF News
FAQ
Q
How do I buy ALPS Medical Breakthroughs ETF (SBIO) stock?
A
You can purchase shares of ALPS Medical Breakthroughs ETF (ARCA:SBIO) through any online brokerage.
Q
Who are ALPS Medical Breakthroughs ETF (SBIO) competitors?
A
There are no as such competitors for ALPS Medical Breakthroughs ETF.
Q
What is the forecast, or price target, for ALPS Medical Breakthroughs ETF (SBIO) stock?
A
There is no analysis for ALPS Medical Breakthroughs ETF to provide a consensus price target.
Q
What is the current price for ALPS Medical Breakthroughs ETF (SBIO)?
A
The stock price for ALPS Medical Breakthroughs ETF (ARCA: SBIO) is $50.58 last updated December 16, 2025 at 3:23 PM EST.
Q
Does ALPS Medical Breakthroughs ETF (SBIO) pay a dividend?
A
There are no upcoming dividends for ALPS Medical Breakthroughs ETF.
Q
When is ALPS Medical Breakthroughs ETF (ARCA:SBIO) reporting earnings?
A
ALPS Medical Breakthroughs ETF does not have any upcoming earnings scheduled.
Q
Is ALPS Medical Breakthroughs ETF (SBIO) going to split?
A
There is no upcoming split for ALPS Medical Breakthroughs ETF.
Key Statistics
Open
$50.93
High
$50.93
52 Wk High
$51.87
AUM
120.32M
Dividend
$0.62
Ex-Div Date
Dec 19, 2024
Volume
52.3K
Market Cap
$2.66B
Mgmt Fee
0.5%
P/E Ratio
10.85
Prev. Close
$50.86
Low
$50.00
52 Wk Low
$22.33
Shares Out
3.20M
Yield
1.21%
Div. Freq
-
Avg. Volume Daily
41.50K
Beta
0.79
Avg. Expense Ratio
0.5%
P/B Ratio
3.15
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | High Performer-High Growth |
| Investment Style | Small Cap Growth |
| Fund Inception | Dec 30, 2014 |
| Managers | Ryan Mischke Charles Perkins |
| Definition | An equity fund portfolio full of stocks with both strong financial performance and superior growth potential |
Investment Policy
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| PCVX | Vaxcyte Inc | 2.53% |
| AXSM | Axsome Therapeutics In... | 3.20% |
| MRUS | Merus Nv | 3.23% |
| RNA | Avidity Biosciences In... | 4.77% |
| RYTM | Rhythm Pharmaceuticals... | 3.63% |
| NUVL | Nuvalent, Inc. | 2.78% |
| CYTK | Cytokinetics Inc | 3.28% |
| KRYS | Krystal Biotech Inc | 2.55% |
| MTSR | Metsera Inc | 2.94% |
| ARWR | Arrowhead Pharmaceutic... | 2.49% |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved